Evidence map›Paper›PMID 39919179›Full record

ArticleScience advances2025

Iryna Stepanenko, Zhishuo Huang, Liviu Ungur, Dimitrios Bessas, Aleksandr Chumakov, Ilya Sergueev, Gabriel E Büchel, Abdullah A Al-Kahtani, Liviu F Chibotaru, Joshua Telser and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Nature communications · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Iryna StepanenkoUniversity of Vienna, Institute of Inorganic Chemistry, Währinger Strasse 42, 1090 Vienna, Austria.ORCID 0000-0002-9406-5539
Zhishuo HuangDepartment of Chemistry, National University of Singapore, Block S8 Level 3, 3 Science Drive 3, Singapore 117543, Singapore.ORCID 0000-0002-9924-8465
Liviu UngurDepartment of Chemistry, National University of Singapore, Block S8 Level 3, 3 Science Drive 3, Singapore 117543, Singapore.ORCID 0000-0001-5015-4225
Dimitrios BessasEuropean Synchrotron Radiation Facility, F-38043 Grenoble, France.ORCID 0000-0003-0240-2540
Aleksandr ChumakovEuropean Synchrotron Radiation Facility, F-38043 Grenoble, France.ORCID 0000-0002-0755-0422
Ilya SergueevDeutsches Elektronen Synchrotron, D-22607 Hamburg, Germany.ORCID 0000-0002-7614-2238
Gabriel E BüchelChemConsult GmbH, P.O. Box 43, 9485 Nendeln, Liechtenstein.ORCID 0000-0002-5055-7099
Abdullah A Al-KahtaniChemistry Department, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-4561-6728
Liviu F ChibotaruTheory of Nanomaterials Group, KU Leuven, Celestijnenlaan 200F, B-3001 Leuven, Belgium.ORCID 0000-0003-1556-0812
Joshua TelserDepartment of Biological, Physical and Health Sciences, Roosevelt University, 430 S. Michigan Avenue, Chicago, IL 60605, USA.ORCID 0000-0003-3307-2556
Vladimir B ArionUniversity of Vienna, Institute of Inorganic Chemistry, Währinger Strasse 42, 1090 Vienna, Austria.ORCID 0000-0002-1895-6460

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osmium complexes with osmium in different oxidation states (II, III, IV, and VI) have been reported to exhibit antiproliferative activity in cancer cell lines. Herein, we demonstrate unexplored opportunities offered by

Indexed as

Coordination ComplexesOsmiumHumansThermodynamicsCoordination ComplexesOsmium

Identifiers

PMID39919179
PMCPMC11804912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.